According to INmune Bio's latest financial reports the company's current earnings are โน0.04 Million. In 2023 the company made an earning of -โน2.57 Billion a decrease over its 2022 earnings that were of -โน2.34 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -โน3.45 Billion | 34.27% |
2023 | -โน2.57 Billion | 9.92% |
2022 | -โน2.34 Billion | -10.02% |
2021 | -โน2.6 Billion | 150.76% |
2020 | -โน1.04 Billion | 57.58% |
2019 | -โน0.66 Billion | -38.28% |
2018 | -โน1.07 Billion |